Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis
Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulation...
Gespeichert in:
Veröffentlicht in: | PloS one 2012-02, Vol.7 (2), p.e32479-e32479 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e32479 |
---|---|
container_issue | 2 |
container_start_page | e32479 |
container_title | PloS one |
container_volume | 7 |
creator | Padhi, Aditya K Kumar, Hirdesh Vasaikar, Suhas V Jayaram, Bhyravabhotla Gomes, James |
description | Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis.
MD simulations were carried out to study the structural and dynamic differences in the catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I, S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms (SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99°. The loss of nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues (31)RRR(33) that result in the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction analyses and molecular docking studies.
Conformational switching of catalytic residue His114 seems to be the mechanism causing loss of ribonucleolytic activity and reduction in SASA of nuclear localization signal residues (31)RRR(33) results in loss of nuclear translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions, and hence would correlate with ALS while K60E would not show any loss. |
doi_str_mv | 10.1371/journal.pone.0032479 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1333201438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A477017311</galeid><doaj_id>oai_doaj_org_article_4e60d246131a4acab83fc082ba8de3c3</doaj_id><sourcerecordid>A477017311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c757t-726c9c7cea89ec707b7e555efd593c79d4ed9e4ae8cf38de7ccca7a0d9565eb43</originalsourceid><addsrcrecordid>eNqNk0tr3DAQx01padK036C0hkJLD7vVy5Z9KYTQx0JKoK-rmJXHthZb2kh2aL59tbtOWJccig6SRr_5SzOaSZKXlCwpl_TDxo3eQrfcOotLQjgTsnyUnNKSs0XOCH98tD5JnoWwISTjRZ4_TU4Y44VgWXmatN9Qt2BN6EPq6rRzYT_Xo9WDcXa_accebAq2Ma5Ba2x6A96AHUJq-m1nNAxYpdEM_a0bvNu2RqddNHro0qA79C6Y8Dx5UkMX8MU0nyW_Pn_6efF1cXn1ZXVxfrnQMpPDQrJcl1pqhKJELYlcS8yyDOsqK7mWZSWwKlEAFrrmRYVSaw0SSFVmeYZrwc-S1wfdbYxFTUkKinLOGaGCF5FYHYjKwUZtvenB3yoHRu0NzjcK_GDiw5XAnFRM5JRTEKBhXfBak4KtIV7NNY9aH6fbxnWPlUY7xKhnovMTa1rVuBvFWVFQSqLAu0nAu-sRw6B6EzR2HVh0Y1Aly2kmcp5F8s0_5MPBTVQD8f3G1vFHQO801bmQklDJKY3U8gEqjgp7o2NB1SbaZw7vZw6RGfDP0MAYglr9-P7_7NXvOfv2iG0RuqENrhv3tTcHxQHUsZqCx_o-x5SoXT_cZUPt-kFN_RDdXh3_z73TXQPwv5uECCU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1333201438</pqid></control><display><type>article</type><title>Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Padhi, Aditya K ; Kumar, Hirdesh ; Vasaikar, Suhas V ; Jayaram, Bhyravabhotla ; Gomes, James</creator><contributor>Langmann, Thomas</contributor><creatorcontrib>Padhi, Aditya K ; Kumar, Hirdesh ; Vasaikar, Suhas V ; Jayaram, Bhyravabhotla ; Gomes, James ; Langmann, Thomas</creatorcontrib><description>Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis.
MD simulations were carried out to study the structural and dynamic differences in the catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I, S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms (SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99°. The loss of nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues (31)RRR(33) that result in the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction analyses and molecular docking studies.
Conformational switching of catalytic residue His114 seems to be the mechanism causing loss of ribonucleolytic activity and reduction in SASA of nuclear localization signal residues (31)RRR(33) results in loss of nuclear translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions, and hence would correlate with ALS while K60E would not show any loss.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0032479</identifier><identifier>PMID: 22384259</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Active Transport, Cell Nucleus ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - genetics ; Amyotrophic Lateral Sclerosis - metabolism ; Analysis ; Angiogenesis ; Angiogenin ; Biochemistry ; Biology ; Catalysis ; Coding ; Crystallography, X-Ray - methods ; Development and progression ; Genetic Variation ; Humans ; Hydrogen ; Hydrogen Bonding ; Hydrogen bonds ; Hypoxia ; Localization ; Medicine ; Models, Molecular ; Molecular docking ; Molecular dynamics ; Molecular Dynamics Simulation ; Mutagenesis ; Mutants ; Mutation ; Neovascularization, Pathologic ; Neural coding ; Neurodegeneration ; Neurons ; Nuclear transport ; Protein Conformation ; Proteins ; Reduction ; Residues ; Ribonuclease, Pancreatic - chemistry ; Ribonuclease, Pancreatic - genetics ; Ribonuclease, Pancreatic - physiology ; Ribosomal DNA ; Risk Factors ; Rodents ; Signal Transduction ; Simulation ; Single nucleotide polymorphisms ; Single-nucleotide polymorphism ; Solvents - chemistry ; Studies ; Surface Properties ; Switching ; Translocation ; Vascular endothelial growth factor</subject><ispartof>PloS one, 2012-02, Vol.7 (2), p.e32479-e32479</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>2012 Padhi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Padhi et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c757t-726c9c7cea89ec707b7e555efd593c79d4ed9e4ae8cf38de7ccca7a0d9565eb43</citedby><cites>FETCH-LOGICAL-c757t-726c9c7cea89ec707b7e555efd593c79d4ed9e4ae8cf38de7ccca7a0d9565eb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288110/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288110/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79472,79473</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22384259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Langmann, Thomas</contributor><creatorcontrib>Padhi, Aditya K</creatorcontrib><creatorcontrib>Kumar, Hirdesh</creatorcontrib><creatorcontrib>Vasaikar, Suhas V</creatorcontrib><creatorcontrib>Jayaram, Bhyravabhotla</creatorcontrib><creatorcontrib>Gomes, James</creatorcontrib><title>Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis.
MD simulations were carried out to study the structural and dynamic differences in the catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I, S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms (SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99°. The loss of nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues (31)RRR(33) that result in the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction analyses and molecular docking studies.
Conformational switching of catalytic residue His114 seems to be the mechanism causing loss of ribonucleolytic activity and reduction in SASA of nuclear localization signal residues (31)RRR(33) results in loss of nuclear translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions, and hence would correlate with ALS while K60E would not show any loss.</description><subject>Active Transport, Cell Nucleus</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - genetics</subject><subject>Amyotrophic Lateral Sclerosis - metabolism</subject><subject>Analysis</subject><subject>Angiogenesis</subject><subject>Angiogenin</subject><subject>Biochemistry</subject><subject>Biology</subject><subject>Catalysis</subject><subject>Coding</subject><subject>Crystallography, X-Ray - methods</subject><subject>Development and progression</subject><subject>Genetic Variation</subject><subject>Humans</subject><subject>Hydrogen</subject><subject>Hydrogen Bonding</subject><subject>Hydrogen bonds</subject><subject>Hypoxia</subject><subject>Localization</subject><subject>Medicine</subject><subject>Models, Molecular</subject><subject>Molecular docking</subject><subject>Molecular dynamics</subject><subject>Molecular Dynamics Simulation</subject><subject>Mutagenesis</subject><subject>Mutants</subject><subject>Mutation</subject><subject>Neovascularization, Pathologic</subject><subject>Neural coding</subject><subject>Neurodegeneration</subject><subject>Neurons</subject><subject>Nuclear transport</subject><subject>Protein Conformation</subject><subject>Proteins</subject><subject>Reduction</subject><subject>Residues</subject><subject>Ribonuclease, Pancreatic - chemistry</subject><subject>Ribonuclease, Pancreatic - genetics</subject><subject>Ribonuclease, Pancreatic - physiology</subject><subject>Ribosomal DNA</subject><subject>Risk Factors</subject><subject>Rodents</subject><subject>Signal Transduction</subject><subject>Simulation</subject><subject>Single nucleotide polymorphisms</subject><subject>Single-nucleotide polymorphism</subject><subject>Solvents - chemistry</subject><subject>Studies</subject><subject>Surface Properties</subject><subject>Switching</subject><subject>Translocation</subject><subject>Vascular endothelial growth factor</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk0tr3DAQx01padK036C0hkJLD7vVy5Z9KYTQx0JKoK-rmJXHthZb2kh2aL59tbtOWJccig6SRr_5SzOaSZKXlCwpl_TDxo3eQrfcOotLQjgTsnyUnNKSs0XOCH98tD5JnoWwISTjRZ4_TU4Y44VgWXmatN9Qt2BN6EPq6rRzYT_Xo9WDcXa_accebAq2Ma5Ba2x6A96AHUJq-m1nNAxYpdEM_a0bvNu2RqddNHro0qA79C6Y8Dx5UkMX8MU0nyW_Pn_6efF1cXn1ZXVxfrnQMpPDQrJcl1pqhKJELYlcS8yyDOsqK7mWZSWwKlEAFrrmRYVSaw0SSFVmeYZrwc-S1wfdbYxFTUkKinLOGaGCF5FYHYjKwUZtvenB3yoHRu0NzjcK_GDiw5XAnFRM5JRTEKBhXfBak4KtIV7NNY9aH6fbxnWPlUY7xKhnovMTa1rVuBvFWVFQSqLAu0nAu-sRw6B6EzR2HVh0Y1Aly2kmcp5F8s0_5MPBTVQD8f3G1vFHQO801bmQklDJKY3U8gEqjgp7o2NB1SbaZw7vZw6RGfDP0MAYglr9-P7_7NXvOfv2iG0RuqENrhv3tTcHxQHUsZqCx_o-x5SoXT_cZUPt-kFN_RDdXh3_z73TXQPwv5uECCU</recordid><startdate>20120227</startdate><enddate>20120227</enddate><creator>Padhi, Aditya K</creator><creator>Kumar, Hirdesh</creator><creator>Vasaikar, Suhas V</creator><creator>Jayaram, Bhyravabhotla</creator><creator>Gomes, James</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120227</creationdate><title>Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis</title><author>Padhi, Aditya K ; Kumar, Hirdesh ; Vasaikar, Suhas V ; Jayaram, Bhyravabhotla ; Gomes, James</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c757t-726c9c7cea89ec707b7e555efd593c79d4ed9e4ae8cf38de7ccca7a0d9565eb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Active Transport, Cell Nucleus</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - genetics</topic><topic>Amyotrophic Lateral Sclerosis - metabolism</topic><topic>Analysis</topic><topic>Angiogenesis</topic><topic>Angiogenin</topic><topic>Biochemistry</topic><topic>Biology</topic><topic>Catalysis</topic><topic>Coding</topic><topic>Crystallography, X-Ray - methods</topic><topic>Development and progression</topic><topic>Genetic Variation</topic><topic>Humans</topic><topic>Hydrogen</topic><topic>Hydrogen Bonding</topic><topic>Hydrogen bonds</topic><topic>Hypoxia</topic><topic>Localization</topic><topic>Medicine</topic><topic>Models, Molecular</topic><topic>Molecular docking</topic><topic>Molecular dynamics</topic><topic>Molecular Dynamics Simulation</topic><topic>Mutagenesis</topic><topic>Mutants</topic><topic>Mutation</topic><topic>Neovascularization, Pathologic</topic><topic>Neural coding</topic><topic>Neurodegeneration</topic><topic>Neurons</topic><topic>Nuclear transport</topic><topic>Protein Conformation</topic><topic>Proteins</topic><topic>Reduction</topic><topic>Residues</topic><topic>Ribonuclease, Pancreatic - chemistry</topic><topic>Ribonuclease, Pancreatic - genetics</topic><topic>Ribonuclease, Pancreatic - physiology</topic><topic>Ribosomal DNA</topic><topic>Risk Factors</topic><topic>Rodents</topic><topic>Signal Transduction</topic><topic>Simulation</topic><topic>Single nucleotide polymorphisms</topic><topic>Single-nucleotide polymorphism</topic><topic>Solvents - chemistry</topic><topic>Studies</topic><topic>Surface Properties</topic><topic>Switching</topic><topic>Translocation</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Padhi, Aditya K</creatorcontrib><creatorcontrib>Kumar, Hirdesh</creatorcontrib><creatorcontrib>Vasaikar, Suhas V</creatorcontrib><creatorcontrib>Jayaram, Bhyravabhotla</creatorcontrib><creatorcontrib>Gomes, James</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Padhi, Aditya K</au><au>Kumar, Hirdesh</au><au>Vasaikar, Suhas V</au><au>Jayaram, Bhyravabhotla</au><au>Gomes, James</au><au>Langmann, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-02-27</date><risdate>2012</risdate><volume>7</volume><issue>2</issue><spage>e32479</spage><epage>e32479</epage><pages>e32479-e32479</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Mutations in the coding region of angiogenin (ANG) gene have been found in patients suffering from Amyotrophic Lateral Sclerosis (ALS). Neurodegeneration results from the loss of angiogenic ability of ANG (protein coded by ANG). In this work, we performed extensive molecular dynamics (MD) simulations of wild-type ANG and disease associated ANG variants to elucidate the mechanism behind the loss of ribonucleolytic activity and nuclear translocation activity, functions needed for angiogenesis.
MD simulations were carried out to study the structural and dynamic differences in the catalytic site and nuclear localization signal residues between WT-ANG (Wild-type ANG) and six mutants. Variants K17I, S28N, P112L and V113I have confirmed association with ALS, while T195C and A238G single nucleotide polymorphisms (SNPs) encoding L35P and K60E mutants respectively, have not been associated with ALS. Our results show that loss of ribonucleolytic activity in K17I is caused by conformational switching of the catalytic residue His114 by 99°. The loss of nuclear translocation activity of S28N and P112L is caused by changes in the folding of the residues (31)RRR(33) that result in the reduction in solvent accessible surface area (SASA). Consequently, we predict that V113I will exhibit loss of angiogenic properties by loss of nuclear translocation activity and L35P by loss of both ribonucleolytic activity and nuclear translocation activity. No functional loss was inferred for K60E. The MD simulation results were supported by hydrogen bond interaction analyses and molecular docking studies.
Conformational switching of catalytic residue His114 seems to be the mechanism causing loss of ribonucleolytic activity and reduction in SASA of nuclear localization signal residues (31)RRR(33) results in loss of nuclear translocation activity in ANG mutants. Therefore, we predict that L35P mutant, would exhibit loss of angiogenic functions, and hence would correlate with ALS while K60E would not show any loss.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>22384259</pmid><doi>10.1371/journal.pone.0032479</doi><tpages>e32479</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2012-02, Vol.7 (2), p.e32479-e32479 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1333201438 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Active Transport, Cell Nucleus Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - genetics Amyotrophic Lateral Sclerosis - metabolism Analysis Angiogenesis Angiogenin Biochemistry Biology Catalysis Coding Crystallography, X-Ray - methods Development and progression Genetic Variation Humans Hydrogen Hydrogen Bonding Hydrogen bonds Hypoxia Localization Medicine Models, Molecular Molecular docking Molecular dynamics Molecular Dynamics Simulation Mutagenesis Mutants Mutation Neovascularization, Pathologic Neural coding Neurodegeneration Neurons Nuclear transport Protein Conformation Proteins Reduction Residues Ribonuclease, Pancreatic - chemistry Ribonuclease, Pancreatic - genetics Ribonuclease, Pancreatic - physiology Ribosomal DNA Risk Factors Rodents Signal Transduction Simulation Single nucleotide polymorphisms Single-nucleotide polymorphism Solvents - chemistry Studies Surface Properties Switching Translocation Vascular endothelial growth factor |
title | Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A07%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanisms%20of%20loss%20of%20functions%20of%20human%20angiogenin%20variants%20implicated%20in%20amyotrophic%20lateral%20sclerosis&rft.jtitle=PloS%20one&rft.au=Padhi,%20Aditya%20K&rft.date=2012-02-27&rft.volume=7&rft.issue=2&rft.spage=e32479&rft.epage=e32479&rft.pages=e32479-e32479&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0032479&rft_dat=%3Cgale_plos_%3EA477017311%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1333201438&rft_id=info:pmid/22384259&rft_galeid=A477017311&rft_doaj_id=oai_doaj_org_article_4e60d246131a4acab83fc082ba8de3c3&rfr_iscdi=true |